Economic value of dispensing home-based preoperative chlorhexidine bathing cloths to prevent surgical site infection

Infection Control and Hospital Epidemiology

Volumn 32, Issue 5, 2011, Pages 465-471

  Bailey, Rachel R ^a,b,c   Stuckey, Dianna R ^a,b,c   Norman, Bryan A ^d   Duggan, Andrew P ^d   Bacon, Kristina M ^a,b,c   Connor, Diana L ^a,b,c   Lee, Ingi ^e,f   Muder, Robert R ^g   Lee, Bruce Y ^a,b,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^d University of Pittsburgh   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE;

ARTICLE; BATH; CLOTHING; DRUG EFFICACY; HEALTH CARE COST; HOSPITAL; HUMAN; LENGTH OF STAY; ORTHOPEDICS; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PREOPERATIVE PERIOD; SIMULATION; SOCIOECONOMICS; STOCHASTIC MODEL; SURGICAL INFECTION; SURGICAL PATIENT; SURGICAL SITE INFECTION;

ANTI-INFECTIVE AGENTS, LOCAL; BATHS; CHLORHEXIDINE; COMPUTER SIMULATION; COST-BENEFIT ANALYSIS; DECISION MAKING, COMPUTER-ASSISTED; HOSPITAL COSTS; HUMANS; MODELS, ECONOMIC; ORTHOPEDIC PROCEDURES; PATIENT COMPLIANCE; PREOPERATIVE CARE; SELF ADMINISTRATION; SURGICAL WOUND INFECTION;

EID: 79955492556     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/659763     Document Type: Article

References (27)

1. Graves N, Harbarth S, Beyersmann J, Barnett A, Halton K, Cooper B. Estimating the cost of health care-associated infections: mind your p's and q's. Clin Infect Dis 2010;50(7):1017-1021.
2. de Lissovoy G, Fraeman K, Hutchins V, Murphy D, Song D, Vaughn BB. Surgical site infection: incidence and impact on hospital utilization and treatment costs. Am J Infect Control 2009; 37(5):387-397.
3. Evans RP. Surgical site infection prevention and control: an emerging paradigm. J Bone Joint Surg Am 2009;91(suppl 6):2-9.
4. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR; Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol 1999;20(4):250-278.
5. Lee BY, Tsui BY, Bailey RR, et al. Should vascular surgery patients be screened preoperatively for methicillin-resistant Staphylococcus aureus? Infect Control Hosp Epidemiol 2009;30(12):1158-1165.
6. Lee BY, Wiringa AE, Bailey RR, et al. Screening cardiac surgery patients for MRSA: an economic computer model. Am J Manag Care 2010;16(7):e163-e173.
7. Webster J, Osborne S. Preoperative bathing or showering with skin antiseptics to prevent surgical site infection. Cochrane Database Syst Rev 2007(2):CD004985.
8. Edmiston CE Jr, Krepel CJ, Seabrook GR, Lewis BD, Brown KR, Towne JB. Preoperative shower revisited: can high topical antiseptic levels be achieved on the skin surface before surgical admission? J Am Coll Surg 2008;207(2):233-239.
9. Johnson AJ, Daley JA, Zywiel MG, Delanois RE, Mont MA. Preoperative chlorhexidine preparation and the incidence of surgical site infections after hip arthroplasty. J Arthroplasty 2010; 25(6 suppl 1):98-102.
10. Zywiel MG, Daley JA, Delanois RE, Naziri Q, Johnson AJ, Mont MA. Advance pre-operative chlorhexidine reduces the incidence of surgical site infections in knee arthroplasty. Int Orthop doi:10.1007/s00264-010-1078-5. Published June 20, 2010.
11. Gold MR, Franks P, McCoy KI, Fryback DG. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. Med Care 1998;36(6):778-792.
12. Kampf G, Kramer A. Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubs. Clin Microbiol Rev 2004;17(4):863-893.
13. Garibaldi RA. Prevention of intraoperative wound contamination with chlorhexidine shower and scrub. J Hosp Infect 1988; 11(suppl B):5-9.
14. Lee I, Agarwal RK, Lee BY, Fishman NO, Umscheid CA. Systematic review and cost analysis comparing use of chlorhexidine with use of iodine for preoperative skin antisepsis to prevent surgical site infection. Infect Control Hosp Epidemiol 2010;31(12): 1219-1229.
15. Maragakis LL, Perencevich EN, Cosgrove SE. Clinical and economic burden of antimicrobial resistance. Expert Rev Anti Infect Ther 2008;6(5):751-763.
16. Laupacis A, Feeny D, Detsky AS, Tugwell PX. How attractive does a new technology have to be to warrant adoption and utilization? tentative guidelines for using clinical and economic evaluations. CMAJ 1992;146(4):473-481.
17. Thompson SG, Nixon RM. How sensitive are cost-effectiveness analyses to choice of parametric distributions? Med DecisMaking 2005;25(4):416-423.
18. Farley JE, Stamper PD, Ross T, Cai M, Speser S, Carroll KC. Comparison of the BD GeneOhm methicillin-resistant Staphylococcus aureus (MRSA) PCR assay to culture by use of BBL CHROMagar MRSA for detection of MRSA in nasal surveillance cultures from an at-risk community population. J ClinMicrobiol 2008;46(2):743-746.
19. Shepard DS. Cost-effectiveness in health and medicine. By M.R. Gold, J.E Siegel, L.B. Russell, and M.C. Weinstein (eds). New York: Oxford University Press, 1996. J Ment Health Policy Econ 1999;2(2):91-92.
20. Tengs TO, Wallace A. One thousand health-related quality-oflife estimates. Med Care 2000;38(6):583-637.
21. Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA. Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 1994;45(3):890-896.
22. + T cells to extracellular matrix ligands in patients with end stage renal failure. Isr Med Assoc J 2000;2(4):282-286.
23. Anandh U, Bastani B, Ballal S. Granulocyte-macrophage colonystimulating factor as an adjuvant to hepatitis B vaccination in maintenance hemodialysis patients. Am J Nephrol 2000;20(1): 53-56.
24. Fabrizi F, Ganeshan SV, Dixit V, Martin P. Meta-analysis: the adjuvant role of granulocyte macrophage-colony stimulating factor on immunological response to hepatitis B virus vaccine in end-stage renal disease. Aliment Pharmacol Ther 2006;24(5): 789-796.
25. Jha R, Lakhtakia S, Jaleel MA, Narayan G, Hemlatha K. Granulocyte macrophage colony stimulating factor (GM-CSF) induced sero-protection in end stage renal failure patients to hepatitis B in vaccine non-responders. Ren Fail 2001;23(5):629-636.
26. Singh NP, Mandal SK, Thakur A, et al. Efficacy of GM-CSF as an adjuvant to hepatitis B vaccination in patients with chronic renal failure-results of a prospective, randomized trial. Ren Fail 2003;25(2):255-266.
27. Sudhagar K, Chandrasekar S, Rao MS, Ravichandran R. Effect of granulocyte macrophage colony stimulating factor on hepatitis-B vaccination in haemodialysis patients. J Assoc Physicians India 1999;47(6):602-604.